Nutan Pharmacy Limited Filleted Accounts Cover
Registered number
05905488
Nutan Pharmacy Limited
Filleted Accounts
31 March 2025
Nutan Pharmacy Limited Balance Sheet Registrar
at
31 March 2025
Company No.
05905488
Notes
2025
2024
£
£
Fixed assets
Intangible assets
4
--
Tangible assets
5
47,22353,466
Investments
6
100100
47,32353,566
Current assets
Stocks
7
86,310
85,903
Debtors
8
299,269
268,794
Cash at bank and in hand
21,095
64,700
406,674
419,397
Creditors: Amount falling due within one year
9
(348,149)
()
(395,759)
()
Net current assets
58,525
23,638
Total assets less current liabilities
105,84877,204
Net assets
105,84877,204
Capital and reserves
Called up share capital
100100
Profit and loss account
10
105,74877,104
Total equity
105,84877,204
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 11 December 2025 and signed on its behalf by:
M. Patel
Director
11 December 2025
Nutan Pharmacy Limited Notes to the Accounts Registrar
for the year ended 31 March 2025
1
General information
Nutan Pharmacy Limited is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 05905488
Its registered office is:
Bank Chambers
1 3 Woodford Avenue
Gants Hill Ilford
Essex
IG2 6UF
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Plant and machinery
15% reducing balanc
3
Employees
2025
2024
Number
Number
The average monthly number of employees (including directors) during the year was:
66
4
Intangible fixed assets
Goodwill
Total
£
£
Cost
At 1 April 2024
980,000980,000
At 31 March 2025
980,000980,000
Amortisation and impairment
At 1 April 2024
980,000980,000
At 31 March 2025
980,000980,000
Net book values
At 31 March 2025
--
At 31 March 2024
--
5
Tangible fixed assets
Land and buildings
Plant and machinery
Total
£
£
£
Cost or revaluation
At 1 April 2024
9,823177,443187,266
Additions
-357357
At 31 March 2025
9,823177,800187,623
Depreciation
At 1 April 2024
-133,800133,800
Charge for the year
-6,6006,600
At 31 March 2025
-140,400140,400
Net book values
At 31 March 2025
9,82337,40047,223
At 31 March 2024
9,823
43,643
53,466
6
Investments held as current assets
Investments
Total
£
£
Cost or valuation
At 1 April 2024
100
100
At 31 March 2025
100
100
Provisions/Impairment
Net book values
At 31 March 2025
100
100
At 31 March 2024
100
100
7
Stocks
2025
2024
£
£
Raw materials and consumables
86,31085,903
86,31085,903
8
Debtors
2025
2024
£
£
Trade debtors
104,217109,157
Loan to holding company
193,385122,371
Corporation tax recoverable
-4,289
Other debtors
1,66732,977
299,269268,794
9
Creditors:
amounts falling due within one year
2025
2024
£
£
Trade creditors
307,332333,501
Taxes and social security
(27,563)
2,108
Loans from directors
56,38949,184
Other creditors
11,99110,966
348,149395,759
10
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
11
Dividends
2025
2024
£
£
Dividends for the period:
Dividends paid in the period
24,000
24,000
24,000
24,000
Dividends by type:
Equity dividends
24,00024,000
24,000
24,000
Nutan Pharmacy Limited0590548831 March 202501 April 2024false11 December 2025BTCSoftware AP Solution 2025 12.1.0212.1.0286,31085,903299,269268,79421,09564,700406,674419,397348,149395,759true059054882024-04-012025-03-31059054882025-03-31059054882024-03-3105905488core:WithinOneYear2025-03-3105905488core:WithinOneYear2024-03-3105905488core:ShareCapital2025-03-3105905488core:ShareCapital2024-03-3105905488core:RetainedEarningsAccumulatedLosses2025-03-3105905488core:RetainedEarningsAccumulatedLosses2024-03-3105905488countries:UnitedKingdom2024-04-012025-03-3105905488bus:RegisteredOffice2024-04-012025-03-3105905488core:PlantMachinery2024-04-012025-03-31059054882023-04-012024-03-3105905488core:Goodwill2024-04-01059054882024-04-0105905488core:Goodwill2025-03-3105905488core:Goodwill2024-03-3105905488core:LandBuildings2024-04-0105905488core:PlantMachinery2024-04-0105905488core:LandBuildings2024-04-012025-03-3105905488core:LandBuildings2025-03-3105905488core:PlantMachinery2025-03-3105905488core:CostValuation2024-04-0105905488core:CostValuation2025-03-3105905488core:CostValuationcore:UnlistedNon-exchangeTraded2025-03-3105905488core:RetainedEarningsAccumulatedLosses2024-04-012025-03-3105905488bus:AllOrdinaryShares2024-04-012025-03-3105905488bus:SmallEntities2024-04-012025-03-3105905488bus:FullAccounts2024-04-012025-03-3105905488bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3105905488bus:Director22024-04-012025-03-3105905488bus:PrivateLimitedCompanyLtd2024-04-012025-03-31iso4217:GBPxbrli:pure